triazoles has been researched along with teriflunomide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Greenhaw, J; Salminen, WF; Shi, Q; Yang, X | 1 |
Cai, L; Gong, P; Lu, K; Wu, G; Xu, C; Zhang, X; Zhao, Y | 1 |
Chadwick, AE; French, NS; Jones, SW; Park, BK; Penman, SL | 1 |
3 other study(ies) available for triazoles and teriflunomide
Article | Year |
---|---|
Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes.
Topics: Aniline Compounds; Animals; Benzoflavones; Biomarkers; Cell Survival; Cells, Cultured; Crotonates; Cytochrome P-450 Enzyme System; Hepatocytes; Hydroxybutyrates; Inactivation, Metabolic; Isoxazoles; Ketoconazole; Leflunomide; Liver; Male; Nitriles; Primary Cell Culture; Proadifen; Rats; Rats, Sprague-Dawley; Ticlopidine; Toluidines; Triazoles | 2011 |
Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors.
Topics: Benzamides; Binding Sites; Crotonates; Dihydroorotate Dehydrogenase; Drug Design; Drug Stability; Enzyme Assays; Enzyme Inhibitors; Humans; Hydroxybutyrates; Immunosuppressive Agents; Leukocytes, Mononuclear; Microsomes, Liver; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Stereoisomerism; Structure-Activity Relationship; Toluidines; Triazoles | 2018 |
Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Biphenyl Compounds; Cell Line; Cell Respiration; Crotonates; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Humans; Hydroxybutyrates; Immunosuppressive Agents; Leflunomide; Liver; Mitochondria; Models, Biological; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Salicylanilides; Toluidines; Triazoles | 2021 |